• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种稳态模板模型,该模型描述了天然组织型纤溶酶原激活剂以及缺乏指状结构域或kringle-2结构域的变体对纤维蛋白刺激的[Glu1]-和[Lys78]纤溶酶原激活的动力学。

A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.

作者信息

Horrevoets A J, Pannekoek H, Nesheim M E

机构信息

Department of Biochemistry, Queen's University, Kingston, Ontario K7L 3N6, Canada.

出版信息

J Biol Chem. 1997 Jan 24;272(4):2183-91. doi: 10.1074/jbc.272.4.2183.

DOI:10.1074/jbc.272.4.2183
PMID:9036151
Abstract

The kinetics of activation of both [Glu1]- and [Lys78]Plg(S741C-fluorescein by native (recombinant) tissue-type plasminogen activator and its deletion variants lacking either the finger or kringle-2 domain were measured by fluorescence within fully polymerized fibrin clots. The kinetics conform to the Michaelis-Menten equation at any fixed fibrin concentration so long as the plasminogen concentration is expressed as either the free or fibrin-bound, but not the total. The apparent kcat and Km values both vary systematically with the concentration of fibrin. Competition kinetics disclosed an active site-dependent interaction between t-Pa and [Glu1]Plg(S741C-fluorescein) in the presence, but not the absence, of fibrin. A steady-state template model having the rate equation v/[A]o = kcat(app).[Plg]/(Km(app) + [Plg]) was derived and used to interpret the data. The model indicates that catalytic efficiency is determined by the stability of the ternary activator-fibrin-plasminogen complex rather than the binding of the activator or plasminogen to fibrin. This implies that efforts to improve the enzymatic properties of t-PA might be more fruitfully directed at enhancing the stability of the ternary complex rather than fibrin binding.

摘要

通过荧光法测定了天然(重组)组织型纤溶酶原激活剂及其缺失指状结构域或kringle-2结构域的缺失变体对[Glu1]-和[Lys78]Plg(S741C-荧光素)的激活动力学,实验在完全聚合的纤维蛋白凝块中进行。只要将纤溶酶原浓度表示为游离或纤维蛋白结合形式而非总浓度,在任何固定的纤维蛋白浓度下,动力学均符合米氏方程。表观催化常数(kcat)和米氏常数(Km)值均随纤维蛋白浓度而系统变化。竞争动力学揭示,在有纤维蛋白存在而非不存在时,t-PA与[Glu1]Plg(S741C-荧光素)之间存在活性位点依赖性相互作用。推导了一个稳态模板模型,其速率方程为v/[A]o = kcat(app).[Plg]/(Km(app) + [Plg]),并用于解释数据。该模型表明,催化效率由三元激活剂-纤维蛋白-纤溶酶原复合物的稳定性决定,而非激活剂或纤溶酶原与纤维蛋白的结合。这意味着,改善t-PA酶学性质的努力可能更有效地针对增强三元复合物的稳定性,而非纤维蛋白结合。

相似文献

1
A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.一种稳态模板模型,该模型描述了天然组织型纤溶酶原激活剂以及缺乏指状结构域或kringle-2结构域的变体对纤维蛋白刺激的[Glu1]-和[Lys78]纤溶酶原激活的动力学。
J Biol Chem. 1997 Jan 24;272(4):2183-91. doi: 10.1074/jbc.272.4.2183.
2
Interaction of plasminogen and fibrin in plasminogen activation.纤溶酶原激活过程中纤溶酶原与纤维蛋白的相互作用。
J Biol Chem. 1990 Nov 15;265(32):19658-64.
3
The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis.组织型纤溶酶原激活剂的手指结构域和kringle 2结构域在体外纤维蛋白溶解过程中的特定作用。
J Biol Chem. 1994 Apr 29;269(17):12639-44.
4
Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.组织型纤溶酶原激活剂与尿激酶型纤溶酶原激活剂杂交体中的结构域间相互作用
Protein Eng. 1995 Dec;8(12):1295-1302. doi: 10.1093/protein/8.12.1295.
5
Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease.
J Biol Chem. 1997 Jan 24;272(4):2176-82. doi: 10.1074/jbc.272.4.2176.
6
Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.组织型纤溶酶原激活剂及其底物谷氨酸纤溶酶原在有限的纤溶酶消化的纤维蛋白中共享共同的结合位点。
J Biol Chem. 1990 Aug 15;265(23):13547-52.
7
Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.纤溶酶原、组织型和吸血蝙蝠纤溶酶原激活剂与纤维蛋白原、纤维蛋白以及与E片段非共价连接的D-二聚体复合物之间相互作用的表征
J Biol Chem. 1998 Jul 17;273(29):18292-9. doi: 10.1074/jbc.273.29.18292.
8
Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator.前基质溶解素-1(前基质金属蛋白酶-3)通过组织型纤溶酶原激活剂刺激纤溶酶原激活。
Eur J Biochem. 2000 Nov;267(21):6378-84. doi: 10.1046/j.1432-1327.2000.01732.x.
9
Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.脂蛋白(a)对纤溶酶原与纤维蛋白结合及其被纤维蛋白结合的组织型纤溶酶原激活物激活的影响。
Chem Phys Lipids. 1994 Jan;67-68:369-80. doi: 10.1016/0009-3084(94)90159-7.
10
[The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].[kringle K1 - 3、K4和K5对组织激活剂激活谷氨酸纤溶酶原和赖氨酸纤溶酶原所引起的纤维蛋白凝块溶解的影响]
Ukr Biokhim Zh (1978). 1989 Jul-Aug;61(4):31-6.

引用本文的文献

1
Micrometer-scale tPA beads amplify plasmin generation for enhanced thrombolytic therapy.微米级组织型纤溶酶原激活剂(tPA)微珠可增强纤溶酶生成,用于强化溶栓治疗。
Bioeng Transl Med. 2025 Mar 3;10(4):e70012. doi: 10.1002/btm2.70012. eCollection 2025 Jul.
2
Harnessing micrometer-scale tPA beads for high plasmin generation and accelerated fibrinolysis.利用微米级组织型纤溶酶原激活剂(tPA)微珠实现高纤溶酶生成和加速纤维蛋白溶解。
bioRxiv. 2024 Nov 8:2024.11.06.621942. doi: 10.1101/2024.11.06.621942.
3
The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment.
纤维蛋白溶解系统及其检测:用于诊断和治疗的历史、当前用途和未来方向。
Int J Mol Sci. 2023 Sep 16;24(18):14179. doi: 10.3390/ijms241814179.
4
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.脂蛋白(a)在动脉粥样硬化疾病中的作用:从病理生理学到诊断与治疗。
Molecules. 2023 Jan 18;28(3):969. doi: 10.3390/molecules28030969.
5
Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen.微滚轮共递送组织型纤溶酶原激活物和纤溶酶原以突破纤溶速度限制。
J Thromb Haemost. 2022 Feb;20(2):486-497. doi: 10.1111/jth.15617. Epub 2021 Dec 19.
6
The fibrinolytic system enables the onset of infection in the mosquito vector and the mammalian host.纤维蛋白溶解系统促使蚊虫媒介和哺乳动物宿主发生感染。
Sci Adv. 2021 Feb 5;7(6). doi: 10.1126/sciadv.abe3362. Print 2021 Feb.
7
Measuring fibrinolysis: from research to routine diagnostic assays.测量纤维蛋白溶解:从研究到常规诊断检测。
J Thromb Haemost. 2018 Apr;16(4):652-662. doi: 10.1111/jth.13957. Epub 2018 Feb 17.
8
Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.靶向纤溶酶原激活物抑制剂-1 治疗四环素诱导的兔胸膜损伤。
Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L54-L68. doi: 10.1152/ajplung.00579.2016. Epub 2017 Aug 31.
9
Bleeding related to disturbed fibrinolysis.与纤维蛋白溶解紊乱相关的出血
Br J Haematol. 2016 Oct;175(1):12-23. doi: 10.1111/bjh.14255. Epub 2016 Aug 1.
10
Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin.补体在动脉和静脉血栓形成中的激活是由纤溶酶介导的。
EBioMedicine. 2016 Feb 6;5:175-82. doi: 10.1016/j.ebiom.2016.02.011. eCollection 2016 Mar.